Clinicopathological manifestations of coexistent monoclonal immunoglobulin deposition disease and immunotactoid glomerulopathy
Authors:
Open Access
- 25 August 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 911998
Abstract
Combination of monoclonal immunoglobulin deposition disease (MIDD) and immunotactoid glomerulopathy (ITG) is a rare form of monoclonal immunoglobulin (MIg)-associated renal disease. We retrospectively reviewed the native kidney biopsy specimens at Peking University People’s Hospital from 2011 to 2020. Five patients were diagnosed as MIDD + ITG. Their clinical and pathological characteristics were studied. The typical clinical features were nephritic syndrome and renal dysfunction with prominent anemia, but hematuria was mild. Unlike single MIDD and single ITG, on light microscopy, segmentally distributed mesangial nodular sclerosis on the basis of mesangial matrix hyperplasia was the major lesion. Others including membranoproliferative glomerulonephritis (MPGN)-like lesion, glomerular basement membrane thickness, and mild to moderate mesangial and endothelial proliferations might presented at the same time and in the same glomeruli. On immunofluorescence, MIg, usually monoclonal light chains, deposited along glomerular basement membranes and tubular basement membranes, while the intact MIg or monoclonal heavy chain deposited in the mesangial regions. Corresponding to the depositions on immunofluorescence, punctate “powdery” deposits along glomerular basement membranes and tubular basement membranes under electronic microscopy indicated the presence of MIDD. Microtubular substructures (diameters of 20–50 nm) exhibiting hollow cores arranged in parallel arrays in mesangial regions indicated the presence of ITG. Patients treated with bortezomib-based regimen seemed to have better outcomes. In conclusion, MIDD + ITG is a rare combination form of MIg-associated renal disease. Accurate diagnosis requires the comprehensive pathological investigations.Keywords
Funding Information
- Specialized Research Fund for the Doctoral Program of Higher Education of China (20090001120098)
- National Natural Science Foundation of China (81000296)
This publication has 25 references indexed in Scilit:
- Clinicopathological characteristics and outcomes of light chain deposition disease: an analysis of 48 patients in a single Chinese centerAnnals of Hematology, 2016
- Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition diseaseKidney International, 2015
- Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and bothLeukemia & Lymphoma, 2015
- Diagnosis of monoclonal gammopathy of renal significanceKidney International, 2015
- Immunotactoid glomerulopathy: clinicopathologic and proteomic studyNephrology Dialysis Transplantation, 2012
- Renal Monoclonal Immunoglobulin Deposition DiseaseClinical Journal of the American Society of Nephrology, 2012
- Coexistence of Myeloma Cast Nephropathy, Light Chain Deposition Disease, and Nonamyloid Fibrils in a Patient With Multiple MyelomaAmerican Journal of Kidney Diseases, 2010
- Fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy.2007
- Immuotactoid Glomerulopathy (Fibrillary Glomerulonephritis)Clinical Journal of the American Society of Nephrology, 2006
- Renal monoclonal immunoglobulin deposition disease: the disease spectrum.2001